Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

DIVIGEL 1 MG GEL TRANSDERMICO EN SOBRES EFG - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/DIVIGEL 1 MG GEL TRANSDERMICO EN SOBRES EFG

Approved

STANDARD

DIVIGEL 1 MG GEL TRANSDERMICO EN SOBRES EFG

Orion Corporation🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Apr 10, 2025
Approval ID: 7fc39f2caee4cf71
Company: Orion Corporation
Type: Standard

Approval Details

Approval Id: 7fc39f2caee4cf71
Drug Cima Aemps Name: DIVIGEL 1 MG GEL TRANSDERMICO EN SOBRES EFG
Register Number: 89908
Holder Company Name: Orion Corporation
Marketing Company Name: Orion Pharma S.L.
Holder Company Detail Path: /organization/orion-corporation
Authorization Date: 2025-04-10
Dosage Form: GEL TRANSDERMICO EN SOBRE
Dose: 1 mg
Route Of Administration: VÍA TRANSDÉRMICA
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Orion Corporation
Company Detail Path: /organization/orion-corporation

Company Information

Pharmaceutical Company Name: Orion Corporation
Name En: Orion Corporation (Orion Oyj)
Country Name: Finland
City Name: Espoo
Address: Espoo, Finland
Website: https://www.orionpharma.com

Active Ingredients

ESTRADIOL HEMIHIDRATO

1,03 mg/dosis

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Apr 10, 2025

Approval ID

7fc39f2caee4cf71

Type

Standard

Back to CIMA-AEMPS Approvals